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Background. While laparoscopy is currently adopted for hepatic resections, robotic approaches to the liver have not gained wide
acceptance.We decided to analyze the learning curve in the field of robotic liver surgery comparing short-term outcomes between
the first and the second half of our series. Methods. We retrospectively reviewed demographics and clinical data of patients who
underwent robotic liver resection at our institution from July 2014 through September 2017. 60 patients diagnosed with primary
or secondary liver neoplasms or hydatid disease were included in this study. ASA PS >3, heart failure, respiratory insufficiency,
and general contraindication to pneumoperitoneum were exclusion criteria. Results. 60 patients were included. We observed a
statistically significant decrease in operative time (p<0.001), intraoperative blood loss (p=0.01), and postoperative complications
(p<0.001) after 30 cases. From the interpretation of the CUSUM curve, the time of operation appears to be significantly reduced
after the first 30 operations.Discussion. This is the first European analysis of the learning curve for robotic liver resection in anHPB
and liver transplant referral center. However, more studies are needed to confirm such results outside a HPB referral center.This is
crucial to develop formal credentialing protocols for both junior and senior surgeons.
1. Introduction
Over the past decade, the role of laparoscopic liver surgery
has been discussed in three international consensus meetings
held in Louisville, Morioka, and Seoul [1]. As a result,
consensus guidelines were produced in another international
meeting held in Southampton in 2017 [2]. It has been
demonstrated that laparoscopic surgery is currently the gold-
standard for left lateral sectionectomy, and the presence of
at least 2 surgeons proficient in laparoscopic liver surgery
(LLS) is recommended in each HPB center [2, 3]. Con-
versely, robotic approaches to the liver have not gained wide
acceptance. Experience on the da Vinci platform is growing
among many surgeons starting from the pioneering work
of Giulianotti and colleagues [4], but the learning curve
for proficiency has yet to be defined. According to the
report from the second international consensus conference
held in Morioka [5] robotic surgery is considered to be
IDEAL stage 2a [6] (Development)—especially in regard to
instrumentation. In other words, it requires both ongoing
institutional ethical approval and a reporting registry of all
cases before beginning to perform this procedure. Therefore,
it is crucial to define learning and proficiency gain curves
to ensure patients’ safety while developing this technology.
We herein report our experience with robotic surgery of
the liver from a high volume and tertiary referral center for
hepatobiliary surgery and liver transplantation.
2. Methods
2.1. Management of Liver Disease at University of Modena
and Reggio Emilia. The hepato-pancreato-biliary robotic
program started at University of Modena and Reggio Emilia
on July 2014 and 136 procedures have been completed
so far. Indication to surgical resection in our center is
always discussed in a multidisciplinary meeting involving
surgeons, radiologists, hepatologists, and oncologists, as
already described [7]. All the robotic surgical procedures
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were performed by the same surgeon (FDB), who completed
robotic training for the da Vinci Si platform  (Intuitive
Surgical Inc., Milford, CT). He is a fully trained surgeon
in HPB and liver transplant, with previous experience in
minimally invasive surgery of the liver. All procedures were
approved by the institution’s supervisory committee, and this
study was approved by the institutional review board.
All patients diagnosed with either HCC, cholangiocar-
cinoma, metastases, adenoma of the liver, or hydatid dis-
ease were evaluated by preoperative examinations to deter-
mine the liver function with conventional liver function
tests (including Child-Pugh classification), serum alpha-
fetoprotein (AFP), hepatitis B surface antigen, and anti-
hepatitis C virus antibody measurements.
Portal hypertension was assessed by platelet count,
gastro-duodenal endoscopy (EGDS), and measurement of
hepatic vein portal gradient (HVPG) when needed. More-
over, selection criteria included compensated cirrhosis (both
Child A and Child B patients) and non-cirrhotic liver disease,
esophageal varices ≤ grade 1, platelet count ≥ 50 × 109 /L,
American Society of Anesthesiologists (ASA) Score ≤3, and
HVPG <14mmHg. To determine the extent of resection all
patients underwent triphasic computed tomography (CT)
scans, and/or contrast enhanced magnetic resonance (MR)
imaging ASA Physical Status (ASA PS) >3, heart failure,
respiratory insufficiency, and general contraindication to
pneumoperitoneum were exclusion criteria for minimally
invasive liver surgery (MILS) [7]. Patients affected by tumors
showing extensive sub glissonian infiltration or infiltrating
major hepatic vessels were also excluded fromMILS.
Each patient signed an informed consent, at least one day
before the surgical day, which included the authorization to
keep audio-visual material of the surgical procedure and the
perioperative and follow-up data in our institutional prospec-
tively maintained database. After surgery, all patients were
followed at our outpatient clinic at 3- or 6-month intervals.
Follow-up examinations included clinical examination, liver
function tests, and imaging according to the primary disease
and to the multidisciplinary consensus.
2.2. Patient Selection and Data Retrieval. We retrospectively
reviewed demographics and clinical data of patients who
underwent robotic liver resection (RLR) at our institution
from the start of our robotic program in July 2014 through
September 2017. Fenestrations of simple or complicated hep-
atic cysts were excluded from this study. We retrieved demo-
graphics and data from past medical history from patients’
medical files, while intraoperative data were prospectively
collected. Estimated blood loss was calculated as the differ-
ence between volume in the suction system and irrigation
volume. Operative time was considered from the induction of
the pneumoperitoneum to the suture of the trocar insertion
sites, thus including the docking time. Postoperative compli-
cationswere classified using theClavien-DindoClassification
for Surgical Complications [8].
Prospectively collected data, including intraoperative
variables, postoperative complications, and pathological
findings, were analyzed retrospectively.
2.3. Surgical Technique. RLR procedures were performed
using the daVinci Si Surgical System. Patients are usually
positioned in supine 20∘ to 30∘ anti-Trendelemburg and can
be slightly rotated to the left to allow an easier access to
right and posterior segments. The pneumoperitoneum is
induced with the Verres needle technique, from the left upper
abdominal quadrant (Palmer’s point), in patients not present-
ing with splenomegaly or suspect for abdominal adherences
from previous surgeries. An open approach to induce the
pneumoperitoneum is preferred in those cases (Hasson’s
technique). Constant endoabdominal pressure is kept with
the use of the automated insufflator AirSeal (Surgiquest).
Exploratory laparoscopy is always performed before docking
the patient cart of the robot. The disposition of the tro-
cars varies according to patient peculiar conformation and
lesion localization. Intraoperative ultrasound (US) is always
performed to better define tumor size and position, and to
assess the correct transection plane, as already reported [9],
thanks to the image-fusion between the scope and the US.
Parenchymal transection is performed with a combination of
monopolar and bipolar energy, and with the use of daVinci
Harmonic ACE (Ethicon, Somerville, NJ) for deeper layers.
Although the robotic platform still does not support liver-
specific articulated devices for parenchymadissection like the
Cavitron Ultrasonic Surgical Aspirator (CUSA), the correct
use of the available tools allows a safe dissection. For example,
the Maryland forceps can be used as a right angle to precisely
dissect small vessels in the parenchyma thanks to the 7
degrees of freedom of the robotic instruments. After the
sample is extracted, hemostasis and biliostasis are perfected
with fibrin glue and a JP drain tube is usually left in place.
2.4. Statistical Analysis. Continuous variables are expressed
as mean ± standard deviation (SD) or median and range and
compared using Student’s t-test. Categorical variables were
compared using the chi-square test with Yates’s correction as
appropriate. Statistical significance was set for p<0.05. Statis-
tical analysis was performed using SPSS Statistics version 19.0
(IBM, Armonk, New York, USA).
Cumulative Sum Control Chart (CUSUM) analysis was
proposed by Page in 1954 for monitoring small shifts in mean
in any production process.
We applied the CUSUM analysis in monitoring perfor-
mance of our surgical procedures in order to detect adverse
events and trends of unacceptable outcomes. The mean of
strategic variables was calculated and plotted against the
number of procedures performed.
At acceptable level of performance, the CUSUM curve is
flat, while at unacceptable levels of performance the curve
slopes upward or downward and eventually crosses a decision
interval. While this occurs, the CUSUM chart indicates
unsatisfactory performance.
3. Results
3.1. Demographics. 67 patients underwent robotic liver
surgery in the study period. After the exclusion of simple
and complicated cyst fenestration, 60 patients were included
in this study and divided into two consecutive groups, the
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Age (years, mean) 57 (±14.1) 59 (±13.7) 0.65
Male/Female 21/9 20/10 0.78
Child A 28 (93.3%) 27 (90%) 0.64
Child B 2 (6.7%) 3 (10%) 0.64
Liver Cirrhosis 15 (50%) 17 (56.7%) 0.70
Right hepatectomy 2 0 0.15










Segmentectomies 11 11 1
Wedge resections 10 14 0.3
Cystopericystectomies 1 3 0.3
first and the second 30 procedures, to investigate the effect of
a mid-term learning curve (Table 1) [10]. Two patients were
scheduled for robotic surgery in the first period but the pro-
cedures were then aborted due to peritoneal metastasis at the
exploratory laparoscopy.No statistically significant difference
can be identified in terms of age, gender, degree of cirrhosis,
surgical procedure, and preoperative comorbidities. Among
the subgroup of bi-segmentectomies, we found that left lateral
sectionectomies were performed more frequently in the first
period in a statistically significant fashion (p=0.01). The final
number of resections in the first period was 31, since one
patient received two wedge resections in the same procedure,
while no multiple resections were performed in the second
period.
3.2. Intraoperative Outcomes. A statistically significant
improvement was found comparing estimated blood loss
and operative time between the two periods. In detail, we
observed a difference of 118.56 minutes in the operative time
between the first and the second 30 robotic cases (p<0.001).
Similarly, estimated blood loss decreased from 484.3 mean
mL to 337.3 mean mL (p=0.01).
3.3. PostoperativeOutcomes. Therewas nodifference in terms
of postoperative in-hospital stay, as shown in Table 2 [4.9
days (range 2-13) and 4.9 days (range 2-12) in the first
and second period, respectively]. Conversely, a slight but
statistically significant difference was demonstrated in the
incidence of low grade postoperative morbidity, classified
as Clavien-Dindo classes 1 and 2. High grade postoperative
complications (Clavien-Dindo classes 3 and 4) and readmis-
sions were uncommon and did not differ between the two
periods. Final pathology confirmed that the two populations
were homogeneous in terms of indications to surgery.
3.4. Difficulty Index Analysis. We retrospectively analyzed
the difficulty index of the cases included in this study accord-
ing to the scoring system developed and further validated
for laparoscopic liver surgery byWakabayashi and colleagues
[11, 12].The final score is obtained from the sum of 5 difficulty
indices: tumor location, extent of hepatic resection, tumor
size, proximity to a major vessel, and liver function. The
difficulty level is then stratified into 3 categories: low (score
1 to 3), intermediate (score 4 to 6), and high (score 7 to 10).
Over the study period 30% of the procedures were staged
as low level difficulty, 55% intermediate level of difficulty,
and 15% high level of difficulty (see Table 3). We found
that low difficulty cases were 8 and 10 among the two
groups, respectively (p=0.58), the intermediate cases 17 and
16, respectively (p=0.79), and the high difficulty cases 5 and
4, respectively (p=0.72) (Figure 1, Table 2).Themost frequent
difficulty score was 5 in both series.
3.5. Learning Curve Analysis with the CUSUMCurve. Cumu-
lative Sum Control Chart (CUSUM) was developed for mon-
itoring the mean of following continuous variables: length of
hospital stay, operation time, and intraoperative blood loss.
From the interpretation of the CUSUM curve, the time of
operation appears to be significantly reduced after the first 30
operations. In the second phase of the experience, operative
time reaches a plateau that corresponds to themean operating
time (Figure 2).The blood loss curve remained stable towards
the average value that corresponds to 410± 393 cc (Figure 3).
The curve of the hospital stay followed a trend similar to
that of blood loss (Figure 4). This underlines the fact that
intraoperative blood loss is a prognostic factor capable of
affecting patient’s outcomes.
4. Discussion
One of the limitations to the diffusion of robotic surgery is
the definition of a credentialing training. Secondly, surgical
instruments dedicated tominimally invasive liver surgery are
still lacking, and no tools comparable to open parenchymal
transection devices have been developed for the robotic
platform. Moreover, no strong evidences on indications or
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Conversion rate 0 1 0.32
Op. time
(min, mean) 377.16 258.6 <0.001∗
Blood loss
(ml, mean) 484.3 337.3 0.01∗
n. of nodules (mean) 1.27 1.23 0.77
Size
(mm, mean) 34.6 28.4 0.16
Hosp. Stay
(days, mean) 4.9 (2-13) 4.9 (2-12) n.a.
Clavien I-II 19 6 <0.001∗
Clavien III-IV 2 1 0.56
Readmission 0 1 0.33
Mortality (30 d) 0 0 n.a.
HCC 17 18 0.79
CHC 0 1 0.32
Metastasis 5 6 0.74
Adenoma 4 2 0.40
Hydatic cyst 2 3 0.65
Low difficulty score 8 (26.7%) 10 (33.3%) 0.58
Intermediate
difficulty score 17 (56.7%) 16 (53.3%) 0.79
High difficulty score 5 (16.7%) 4 (13.3%) 0.72
Modal score 5 5
Median score 5 4.5
Mean score 4.97 4.67
Standard deviation 2.04 1.86
Low vs Intermediate p= 0.03∗ p= 0.13
Low vs. High p=0.39 p=0.03∗

















Low difficulty Intermediate difficulty High difficulty
Patients’ distribution according to difficulty index
First period
Second period
Figure 1: Distribution of patients according to the difficulty index.
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Table 3: Difficulty index variations.
Patient Score Difficulty Patient Score Difficulty
1 7 high 31 6 intermediate
2 3 low 32 8 high
3 6 intermediate 33 1 low
4 6 intermediate 34 3 low
5 4 low 35 5 intermediate
6 9 high 36 5 intermediate
7 2 low 37 6 intermediate
8 4 low 38 5 intermediate
9 3 low 39 6 intermediate
10 5 intermediate 40 3 low
11 4 intermediate 41 8 high
12 7 high 42 2 low
13 5 intermediate 43 3 low
14 5 intermediate 44 5 intermediate
15 5 intermediate 45 3 low
16 10 high 46 3 low
17 4 intermediate 47 5 intermediate
18 1 low 48 4 intermediate
19 8 high 49 5 intermediate
20 6 intermediate 50 4 intermediate
21 4 intermediate 51 3 low
22 5 intermediate 52 3 low
23 5 intermediate 53 7 high
24 3 low 54 4 intermediate
25 5 intermediate 55 5 intermediate
26 6 intermediate 56 6 intermediate
27 6 intermediate 57 4 intermediate
28 5 intermediate 58 3 low
29 5 intermediate 59 9 high
30 1 low 60 6 intermediate
procedures have been produced. Although some literature
has shown comparable outcomes between robotic and laparo-
scopic hepatic surgery, such results may not be generalizable
[13, 14]. It has been claimed that financial burden may be a
limitation to the diffusion of robotic surgery [15]. However,
the lower rates of postoperative morbidity after robotic
resection, including conversion to open, demonstrate that
the initial cost of purchasing the robot can be overcome by
faster return to daily activity compared to the open approach
group (22% versus 40%; p=0.047) [16, 17]. In this series
we had to convert the resection from robotic approach to
open in one case of right posterior sectionectomy due to gas
embolism.The source of the embolism was probably an intra-
parenchymal hepatic vein rupture while applying a clip. The
patient was desaturing although the bleeding was immedi-
ately controlled; therefore we agreed with the anesthesiologist
to convert to open and quickly complete the resection.
The postoperative course was uneventful and the patient
was ultimately discharged on postoperative day 7th. Some
of the advantages of the robot over standard laparoscopy
are increased dexterity, improved visualization with high-
resolution 3D image, tremor filtration, image fusion, and real-
time integrated indocyanine green. However, it should be
noticed that, despite the similar setting, robotic approach can
be considered more similar to the traditional open surgery
than to laparoscopy. In fact, the immersive experience offered
by the robotic platform and the agility in the manipulation
of tissues recall the environment of standard open technique.
Moreover, the possibility of using a double console allows
a higher level of interaction between the surgeon and the
assistant for teaching purposes. It has been proposed that
these featuresmay allow a shorter learning curve as compared
to standard laparoscopy [18]. Recently, Efanov and colleagues
reported that the skills to perform difficult procedures with
the robot are acquired faster compared to LLR, without
differences in the incidence of postoperative complications
[19].
Our experience shows statistically significant decrease
of estimated blood loss, operative time, and low grade
postoperative morbidities that can be interpreted as a crucial




























































Figure 3: Estimated blood loss CUSUM curve.
improvement to ensure patients’ safety. The low incidence
of high grade postoperative complication, as well as the
low rate of readmissions, clearly demonstrates the ability
of the robotic approach to minimize surgical impact. This
turned to be even more important in the context of cirrhotic
patients, which is evident in our cohort where 16.7% were
Child B patients. In this setting of reduced liver function and
functional reserve, we can benefit from gentle manipulation
on the liver, respect of the venous shunts, and limited surgical
trauma [20, 21]. Moreover, the results were confirmed also


































Figure 4: Hospital stay CUSUM curve.
among the HCC subgroup (17 patients in the first group and
18 patients in the second group, p=0.79) and a safe resection
was granted achieving always a negative margin in both
populations (mean 10.4 cm and 17.1 cm, median 10 cm and
11 cm, respectively, p=0.22).
Indication to surgery and type of resection did not differ
significantly between the two periods, and the different rate
of major hepatectomies is not effect of patient selection.
Moreover, after stratifying patients according to the score
proposed by Wakabayashi and colleagues, we found that the
two populations did not differ in terms of difficulty of the
procedures. That means that the improvement observed is
actually due to better surgical performances. Moreover, the
incidence of intermediate level of difficulty prevailed in a
statistically significant fashion over the study period. It may
seem surprising, but it should be kept in mind that even if it
represents the beginning of the robotic activity, the surgeon
performing the procedures was already skilled in HPB and
minimally invasive surgery [14]. The cultural background is
crucial to develop new techniques, and our results mirror
the experience of our center in the management of HPB
surgery and postoperative care. We may hypothesize that the
learning curve of residents and fellows should be focused
on the correct use of the robotic platform, starting with
easier procedures to get more confident with the console and
the cart. Conversely, fully trained surgeons, in high volume
referral centers, can approach intermediate level procedures
along with some higher level ones. In the latter scenario, we
showed that significant improvements in short-term surgical
outcomes can be achieved after 30 cases. The develop-
ment of robotic surgery for complex operations should be
encouraged, but high quality standards and an ethics-driven
surgical growth must be guaranteed [21].
5. Conclusions
Robotic approach proved to be safe and effective for the
surgical treatment of liver diseases. In our experience, when
analyzing the effects of a “mid-term activity,” a statistically
significant improvement in both intra- and postoperative
outcomes can be noticed. However, more studies are needed
to confirm such results outside a HPB referral center. This
is crucial, in particular to develop formal credentialing
protocols for both junior and senior surgeons.
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